Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPI-8811 (cobiprostone) for PPI-refractory non-erosive reflux disease
jRCT2080222711Phase 2
- Sponsor
- Sucampo
- Start
- Dec 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Non-erosive Gastroesophageal Reflux Disease (NERD) comparing SPI-8811 (cobiprostone) with Placebo (2 arms).
02
Drugs
cobiprostone
03
Conditions
Non-erosive Gastroesophageal Reflux Disease (NERD)
Beyond the preview
Go deeper on jRCT2080222711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222711.